methotrexate 20 MG in 0.4 ML Auto-Injector
- RxCUI
- 1441416
- RxNorm name
- methotrexate 20 MG in 0.4 ML Auto-Injector
- Display name
- methotrexate 20 MG in 0.4 ML Auto-Injector
- Full name
- methotrexate 20 MG in 0.4 ML Auto-Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rasuvo | METHOTREXATE | Medexus Pharma Inc. | d0075461-0e7e-4967-9c9b-d6440e912c0e | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | 1441416 |
| Otrexup | METHOTREXATE | Antares Pharma, Inc. | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 1441416 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | methotrexate 20 MG in 0.4 ML Auto-Injector [PSN] · 0.4 ML methotrexate 50 MG/ML Auto-Injector [SCD] · methotrexate (as methotrexate sodium) 50 MG/ML 0.4 ML Auto-Injector [SY] · methotrexate 20 MG per 0.4 ML Auto-Injector [SY] | 4 | 15 | These highlights do not include all the information needed to use OTREXUP™ safely and effectively. See full prescribing information for OTREXUP . OTREXUP (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953 | 20250131 |
| d0075461-0e7e-4967-9c9b-d6440e912c0e | methotrexate 20 MG in 0.4 ML Auto-Injector [PSN] · 0.4 ML methotrexate 50 MG/ML Auto-Injector [SCD] · methotrexate (as methotrexate sodium) 50 MG/ML 0.4 ML Auto-Injector [SY] · methotrexate 20 MG per 0.4 ML Auto-Injector [SY] | 4 | 10 | These highlights do not include all the information needed to use RASUVO ® safely and effectively. See full prescribing information for RASUVO. RASUVO (methotrexate) injection, for subcutaneous use Initial U.S. Approval: 1953 | 20251215 |